Company research
Park Ha Biological Technology Co., Ltd.
CIK 1986247Updated Sep 24, 2026
SecurityBYAH · NASDAQ · equity
BYAH price & chart
Loading TradingView…
NASDAQ:BYAH on TradingView ↗In the news
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Park Ha Biological Technology Co., Ltd. of Class Action Lawsuit and Upcoming Deadlines – BYAH ↗
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Park Ha Biological Technology Co., Ltd. of Class Action Lawsuit and Upcoming Deadlines - BYAH ↗
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Park Ha Biological Technology Co., Ltd. of Class Action Lawsuit and Upcoming Deadlines - BYAH ↗
Financials
FY 2025 · USDSource
Source
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2025 | FY 2024 |
|---|---|---|
| ASSETS | ||
| AssetsUSD | 5,952,616Source | 3,083,283Source |
| Property, Plant and Equipment, NetUSD | 157,999Source | 103,960Source |
| Intangible Assets, Net (Excluding Goodwill)USD | 6,639Source | 7,621Source |
| Current assets: | ||
| Cash and Cash Equivalents, at Carrying ValueUSD | 3,787,678Source | 547,498Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 255,844Source | 330,892Source |
| Inventory, NetUSD | 75,214Source | 71,486Source |
| Assets, CurrentUSD | 5,501,962Source | 2,844,246Source |
| Operating Lease, Right-of-Use AssetUSD | 180,243Source | 70,739Source |
| Other Assets, NoncurrentUSD | 105,773Source | 56,717Source |
| LIABILITIES AND EQUITY | ||
| LiabilitiesUSD | 1,957,761Source | 1,577,198Source |
| Stockholders’ equity: | ||
| Common Stock, Value, IssuedUSD | — | 500Source |
| Additional Paid in CapitalUSD | — | 1,161,211Source |
| Retained Earnings (Accumulated Deficit)USD | -24,178,267Source | 271,788Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | -66,400Source | -59,376Source |
| Stockholders' Equity Attributable to ParentUSD | 3,994,855Source | 1,506,085Source |
| Additional Paid in Capital, Common StockUSD | 28,021,581Source | 1,161,211Source |
| Liabilities and EquityUSD | 5,952,616Source | 3,083,283Source |
| Current liabilities: | ||
| Liabilities, CurrentUSD | 1,881,846Source | 1,524,453Source |
| Operating Lease, Liability, CurrentUSD | 104,254Source | 17,573Source |
| Accounts Payable, CurrentUSD | 12,013Source | 24,069Source |
| Operating Lease, Liability, NoncurrentUSD | 75,915Source | 52,745Source |
cash flow · annual statements
| Line item | FY 2025 | FY 2024 |
|---|---|---|
| Cash flows from operating activities: | ||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||
| Depreciation and amortization | — | — |
| Share-based Payment Arrangement, Noncash ExpenseUSD | 24,070,200Source | — |
| Changes in operating assets and liabilities: | ||
| Increase (Decrease) in Accounts ReceivableUSD | -71,978Source | 98,740Source |
| Increase (Decrease) in InventoriesUSD | 17,458Source | -10,472Source |
| Increase (Decrease) in Accounts PayableUSD | -11,894Source | -176,130Source |
| Deferred Income Tax Expense (Benefit)USD | -26,671Source | -21,465Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | 85,852Source | 960,470Source |
| Cash flows from investing activities: | ||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | -572,927Source | -508,143Source |
| Cash flows from financing activities: | ||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | 3,735,677Source | -957,389Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 3,787,678Source | 547,498Source |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | -8,422Source | 18,926Source |
| Additional Financial Items | ||
| Amortization of Intangible AssetsUSD | 970Source | 974Source |
| Deferred Other Tax Expense (Benefit)USD | -26,671Source | -21,465Source |
| DepreciationUSD | 108,399Source | 21,712Source |
| General and Administrative ExpenseUSD | 25,483,541Source | 814,857Source |
| Income Tax Expense (Benefit)USD | 280,646Source | 314,860Source |
| InterestExpenseNonoperatingUSD | 41Source | — |
| Inventory Write-downUSD | 1,430Source | 15,955Source |
| Investment Income, InterestUSD | 6,097Source | 783Source |
| Net Income (Loss) Attributable to ParentUSD | -24,364,753Source | 478,561Source |
| Nonoperating Income (Expense)USD | 64,794Source | -293Source |
| Operating ExpensesUSD | 26,531,218Source | 1,392,801Source |
| Operating Lease, ExpenseUSD | 37,386Source | 30,425Source |
| Other Nonoperating Income (Expense)USD | 58,738Source | — |
| Proceeds from Contributed CapitalUSD | — | 500Source |
| Proceeds from Issuance of Common StockUSD | 4,277,807Source | — |
| Financing Receivable, Credit Loss, Expense (Reversal)USD | 183,501Source | -8,580Source |
income statement · annual statements
| Line item | FY 2025 | FY 2024 |
|---|---|---|
| Total RevenueUSD | 2,524,843Source | 2,381,851Source |
| Cost of Goods and Services Sold | — | — |
| Operating Income (Loss)USD | -24,148,901Source | 793,714Source |
| Other Nonoperating Income (Expense)USD | 58,738Source | — |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | -24,084,107Source | 793,421Source |
| Income Tax Expense (Benefit)USD | 280,646Source | 314,860Source |
| Net Income (Loss) Attributable to ParentUSD | -24,364,753Source | 478,561Source |
| Earnings Per Share, BasicUSD per share | -41.38Source | 0.02Source |
| Earnings Per Share, DilutedUSD per share | -41.38Source | 0.02Source |
| Weighted Average Number of Shares Outstanding, Basicshares | 588,866Source | 25,000,000Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 588,866Source | 25,000,000Source |
| Interest Expense (non-operating)USD | 41Source | — |
| Additional Financial Items | ||
| Amortization of Intangible AssetsUSD | 970Source | 974Source |
| Current Income Tax Expense (Benefit)USD | 307,317Source | 336,325Source |
| Depreciation, Depletion and Amortization, NonproductionUSD | 109,369Source | 22,686Source |
| General and Administrative ExpenseUSD | 25,483,541Source | 814,857Source |
| Gross ProfitUSD | 2,382,317Source | 2,186,515Source |
| Investment Income, InterestUSD | 6,097Source | 783Source |
| Nonoperating Income (Expense)USD | 64,794Source | -293Source |
| Operating ExpensesUSD | 26,531,218Source | 1,392,801Source |
| Operating Lease, ExpenseUSD | 37,386Source | 30,425Source |
| Research and Development ExpenseUSD | 238,184Source | 36,714Source |
| Selling and Marketing ExpenseUSD | 625,289Source | 361,327Source |